A key U.S. Centers for Disease Control and Prevention panel voted unanimously to recommend Pfizer-BioNTech’s Covid-19 vaccine for people 16 years and older.
in Business
A key U.S. Centers for Disease Control and Prevention panel voted unanimously to recommend Pfizer-BioNTech’s Covid-19 vaccine for people 16 years and older.

